Vincent Antonucci

Statistics

Publications

Citations

686

H-Index

Active since

1988

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Novartis (Switzerland)

Galapagos (Belgium)

Takeda (United States)

AbbVie (United States)

Vincent Antonucci is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacy, analytical chemistry, and chromatography.

Publications per year

1988–2019

Publications

Toxicological Assessment of 2-Methyltetrahydrofuran and Cyclopentyl Methyl Ether in Support of Their Use in Pharmaceutical Chemical Process Development

Vincent Antonucci, John B. Coleman, James B. Ferry et al. · Organic Process Research & Development · 2011 · 203 citations

Pharmacy, Toxicology, Analytical Toxicology +14

Current challenges and future prospects in chromatographic method development for pharmaceutical research

Frederick T. Mattrey, Alexey A. Makarov, Erik L. Regalado et al. · TrAC Trends in Analytical Chemistry · 2017 · 139 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +17

Removal of Electrophilic Potential Genotoxic Impurities Using Nucleophilic Reactive Resins

Claire Lee, Roy Helmy, Christopher A. Strulson et al. · Organic Process Research & Development · 2010 · 41 citations

Natural Sciences, Chemical Engineering, Chemistry +17

A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies

Chris Barber, Vincent Antonucci, Jens-Christoph Baumann et al. · Regulatory Toxicology and Pharmacology · 2017 · 35 citations

Engineering, Strategy, Process Control +3

Development of LC chiral methods for neutral pharmaceutical related compounds using reversed phase and normal phase liquid chromatography with different types of polysaccharide stationary phases

Lili Zhou, Christopher J. Welch, Clair Lee et al. · Journal of Pharmaceutical and Biomedical Analysis · 2009 · 31 citations

Pharmacy, Pharmaceutical Analysis, Pharmaceutics +16

1–5 of 17